Administration of IL-33 in a murine model of breast cancer resulted in increased tumor growth and development of metastases, which was correlated with increased intratumoral numbers of IL-13-producing ILCs, IL-13 receptor α 1-expressing myeloid-derived suppressor cells (MDSCs) and regulatory T cells (Tregs) [55]. The gene discussed is IL13; the disease is neoplasm.